{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:17:54Z","timestamp":1789989474687,"version":"4.0.1"},"update-to":[{"DOI":"10.1371\/journal.pntd.0005432","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T00:00:00Z","timestamp":1489622400000}}],"reference-count":65,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T00:00:00Z","timestamp":1488758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"The Wellcome Trust","doi-asserted-by":"crossref","award":["095161"],"award-info":[{"award-number":["095161"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1100654"],"award-info":[{"award-number":["1100654"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1053792"],"award-info":[{"award-number":["1053792"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0005432","type":"journal-article","created":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T18:38:12Z","timestamp":1488825492000},"page":"e0005432","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":45,"title":["Selective inhibition of RNA polymerase I transcription as a potential approach to treat African trypanosomiasis"],"prefix":"10.1371","volume":"11","author":[{"given":"Louise E.","family":"Kerry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine E.","family":"Pegg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald P.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Budzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen","family":"Poortinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine M.","family":"Hannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross D.","family":"Hannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1884-4933","authenticated-orcid":true,"given":"Gloria","family":"Rudenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,3,6]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.pt.2015.11.008","article-title":"Beyond Tsetse - Implications for Research and Control of Human African Trypanosomiasis Epidemics","volume":"32","author":"SC Welburn","year":"2016","journal-title":"Trends Parasitol"},{"key":"ref2","first-page":"257","article-title":"Epidemiology of human African trypanosomiasis","volume":"6","author":"JR Franco","year":"2014","journal-title":"Clinical epidemiology"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"e0003785","DOI":"10.1371\/journal.pntd.0003785","article-title":"Monitoring the Progress towards the Elimination of Gambiense Human African Trypanosomiasis","volume":"9","author":"PP Simarro","year":"2015","journal-title":"PLoS neglected tropical diseases"},{"issue":"12","key":"ref4","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1111\/cmi.12215","article-title":"Antigenic variation in African trypanosomes: the importance of chromosomal and nuclear context in VSG expression control","volume":"15","author":"L Glover","year":"2013","journal-title":"Cell Microbiol"},{"issue":"11","key":"ref5","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.tig.2006.08.003","article-title":"Switching trypanosome coats: what's in the wardrobe?","volume":"22","author":"JE Taylor","year":"2006","journal-title":"Trends Genet"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MDNA3-0016-2014","article-title":"DNA Recombination Strategies During Antigenic Variation in the African Trypanosome","volume":"3","author":"R McCulloch","year":"2015","journal-title":"Microbiol Spectr"},{"issue":"12","key":"ref7","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1586\/14787210.2015.1094374","article-title":"Future treatment options for human African trypanosomiasis","volume":"13","author":"AJ Jones","year":"2015","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1179\/2047773213Y.0000000105","article-title":"A current analysis of chemotherapy strategies for the treatment of human African trypanosomiasis","volume":"107","author":"P Babokhov","year":"2013","journal-title":"Pathog Glob Health"},{"issue":"11","key":"ref9","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1586\/14787210.2014.959496","article-title":"Treatment options for second-stage gambiense human African trypanosomiasis","volume":"12","author":"G Eperon","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"9","key":"ref10","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.2217\/fmb.11.88","article-title":"Drug resistance in human African trypanosomiasis","volume":"6","author":"MP Barrett","year":"2011","journal-title":"Future Microbiol"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1017\/S003118201300022X","article-title":"Genetic dissection of drug resistance in trypanosomes","volume":"140","author":"S Alsford","year":"2013","journal-title":"Parasitology"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpddr.2014.02.002","article-title":"Drug repurposing and human parasitic protozoan diseases","volume":"4","author":"KT Andrews","year":"2014","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/j.bmcl.2016.03.103","article-title":"Repurposing strategies for tropical disease drug discovery","volume":"26","author":"DM Klug","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"issue":"10","key":"ref14","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.4155\/fmc.11.92","article-title":"Target repurposing for neglected diseases","volume":"3","author":"MP Pollastri","year":"2011","journal-title":"Future Med Chem"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/bs.apha.2014.06.003","article-title":"Delivery of antihuman African trypanosomiasis drugs across the blood-brain and blood-CSF barriers","volume":"71","author":"GN Sekhar","year":"2014","journal-title":"Adv Pharmacol"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jac\/dkn509","article-title":"Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections","volume":"63","author":"DC Miguel","year":"2009","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijpddr.2015.05.006","article-title":"Leishmania is not prone to develop resistance to tamoxifen","volume":"5","author":"AC Coelho","year":"2015","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1021\/acsinfecdis.5b00136","article-title":"Identification of "Preferred" Human Kinase Inhibitors for Sleeping Sickness Lead Discovery. Are Some Kinases Better than Others for Inhibitor Repurposing?","volume":"2","author":"E Amata","year":"2016","journal-title":"ACS Infect Dis"},{"issue":"11","key":"ref19","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0968-0004(99)01460-7","article-title":"The economics of ribosome biosynthesis in yeast","volume":"24","author":"JR Warner","year":"1999","journal-title":"Trends Biochem Sci"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.bbadis.2013.12.009","article-title":"Targeting the nucleolus for cancer intervention","volume":"1842","author":"JE Quin","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ccr.2012.05.019","article-title":"Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53","volume":"22","author":"MJ Bywater","year":"2012","journal-title":"Cancer Cell"},{"key":"ref22","article-title":"Inhibition of RNA polymerase I transcription initiation by CX-5461 activates non-canonical ATM\/ATR signaling","author":"J Quin","year":"2016","journal-title":"Oncotarget"},{"issue":"8","key":"ref23","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1517\/14728222.2013.818658","article-title":"Targeting RNA polymerase I transcription and the nucleolus for cancer therapy","volume":"17","author":"RD Hannan","year":"2013","journal-title":"Expert Opin Ther Targets"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev.pharmtox.010909.105844","article-title":"The RNA polymerase I transcription machinery: an emerging target for the treatment of cancer","volume":"50","author":"D Drygin","year":"2010","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0092-8674(87)90153-X","article-title":"The anatomy and transcription of a telomeric expression site for variant-specific surface antigens in T. brucei","volume":"51","author":"JM Kooter","year":"1987","journal-title":"Cell"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.gene.2014.09.047","article-title":"Mono-allelic VSG expression by RNA polymerase I in Trypanosoma brucei: expression site control from both ends?","volume":"556","author":"A Gunzl","year":"2015","journal-title":"Gene"},{"issue":"24","key":"ref27","doi-asserted-by":"crossref","first-page":"8716","DOI":"10.1073\/pnas.0501886102","article-title":"Variant surface glycoprotein RNA interference triggers a precytokinesis cell cycle arrest in African trypanosomes","volume":"102","author":"K Sheader","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"ref28","doi-asserted-by":"crossref","first-page":"7653","DOI":"10.1158\/0008-5472.CAN-09-1304","article-title":"Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis","volume":"69","author":"D Drygin","year":"2009","journal-title":"Cancer Res"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1177\/1947601910377493","article-title":"Targeting MYC Expression through G-Quadruplexes","volume":"1","author":"TA Brooks","year":"2010","journal-title":"Genes Cancer"},{"issue":"10","key":"ref30","doi-asserted-by":"crossref","first-page":"12368","DOI":"10.3390\/molecules181012368","article-title":"G-quadruplex structures in the human genome as novel therapeutic targets","volume":"18","author":"J Bidzinska","year":"2013","journal-title":"Molecules"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd3428","article-title":"Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?","volume":"10","author":"S Balasubramanian","year":"2011","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"ref32","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1021\/ml300110s","article-title":"Discovery of CX-5461, the First Direct and Selective Inhibitor of RNA Polymerase I, for Cancer Therapeutics","volume":"3","author":"M Haddach","year":"2012","journal-title":"ACS Med Chem Lett"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1158\/0008-5472.CAN-10-1728","article-title":"Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth","volume":"71","author":"D Drygin","year":"2011","journal-title":"Cancer Res"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1158\/2159-8290.CD-14-0673","article-title":"Combination Therapy Targeting Ribosome Biogenesis and mRNA Translation Synergistically Extends Survival in MYC-Driven Lymphoma","volume":"6","author":"JR Devlin","year":"2016","journal-title":"Cancer Discov"},{"issue":"7","key":"ref35","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.bbagrm.2014.10.007","article-title":"The nucleolus as a fundamental regulator of the p53 response and a new target for cancer therapy","volume":"1849","author":"SJ Woods","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"ref36","doi-asserted-by":"crossref","first-page":"e12996","DOI":"10.1371\/journal.pone.0012996","article-title":"Identification of novel p53 pathway activating small-molecule compounds reveals unexpected similarities with known therapeutic agents","volume":"5","author":"K Peltonen","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2013.12.009","article-title":"A targeting modality for destruction of RNA polymerase I that possesses anticancer activity","volume":"25","author":"K Peltonen","year":"2014","journal-title":"Cancer Cell"},{"issue":"45","key":"ref38","doi-asserted-by":"crossref","first-page":"26954","DOI":"10.1074\/jbc.M115.679019","article-title":"Identification of the ISWI Chromatin Remodeling Complex of the Early Branching Eukaryote Trypanosoma brucei","volume":"290","author":"TM Stanne","year":"2015","journal-title":"J Biol Chem"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0166-6851(99)00002-X","article-title":"A tightly regulated inducible expression system for conditional gene knock-outs and dominant-negative genetics in Trypanosoma brucei","volume":"99","author":"E Wirtz","year":"1999","journal-title":"Mol Biochem Parasitol"},{"issue":"14","key":"ref40","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1074\/jbc.M312307200","article-title":"Bloodstream form-specific up-regulation of silent vsg expression sites and procyclin in Trypanosoma brucei after inhibition of DNA synthesis or DNA damage","volume":"279","author":"K Sheader","year":"2004","journal-title":"J Biol Chem"},{"issue":"11","key":"ref41","doi-asserted-by":"crossref","first-page":"e1003010","DOI":"10.1371\/journal.ppat.1003010","article-title":"Histone H1 plays a role in heterochromatin formation and VSG expression site silencing in Trypanosoma brucei","volume":"8","author":"ML Povelones","year":"2012","journal-title":"PLoS Pathog"},{"issue":"5","key":"ref42","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1128\/EC.00036-12","article-title":"The trypanosomatid-specific N terminus of RPA2 is required for RNA polymerase I assembly, localization, and function","volume":"11","author":"JP Daniels","year":"2012","journal-title":"Eukaryot Cell"},{"issue":"26","key":"ref43","doi-asserted-by":"crossref","first-page":"7225","DOI":"10.1073\/pnas.1600344113","article-title":"VEX1 controls the allelic exclusion required for antigenic variation in trypanosomes","volume":"113","author":"L Glover","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"ref44","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0001-706X(97)00079-X","article-title":"The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro","volume":"68","author":"B Raz","year":"1997","journal-title":"Acta Trop"},{"issue":"18","key":"ref45","first-page":"6075","article-title":"Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10","volume":"50","author":"HD Soule","year":"1990","journal-title":"Cancer Res"},{"issue":"6743","key":"ref46","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/22780","article-title":"Creation of human tumour cells with defined genetic elements","volume":"400","author":"WC Hahn","year":"1999","journal-title":"Nature"},{"issue":"4","key":"ref47","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1091\/mbc.E06-09-0841","article-title":"Diversification of function by different isoforms of conventionally shared RNA polymerase subunits","volume":"18","author":"S Devaux","year":"2007","journal-title":"Mol Biol Cell"},{"issue":"3","key":"ref48","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1128\/EC.2.3.542-551.2003","article-title":"RNA polymerase I transcribes procyclin genes and variant surface glycoprotein gene expression sites in Trypanosoma brucei","volume":"2","author":"A Gunzl","year":"2003","journal-title":"Eukaryot Cell"},{"issue":"10","key":"ref49","doi-asserted-by":"crossref","first-page":"e3527","DOI":"10.1371\/journal.pone.0003527","article-title":"Telomeric expression sites are highly conserved in Trypanosoma brucei","volume":"3","author":"C Hertz-Fowler","year":"2008","journal-title":"PLoS One"},{"issue":"6865","key":"ref50","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/414759a","article-title":"A pol I transcriptional body associated with VSG mono-allelic expression in Trypanosoma brucei","volume":"414","author":"M Navarro","year":"2001","journal-title":"Nature"},{"issue":"3-4","key":"ref51","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.vetpar.2010.01.019","article-title":"In vitro activity and preliminary toxicity of various diamidine compounds against Trypanosoma evansi","volume":"169","author":"K Gillingwater","year":"2010","journal-title":"Vet Parasitol"},{"issue":"23","key":"ref52","doi-asserted-by":"crossref","first-page":"9471","DOI":"10.1093\/nar\/14.23.9471","article-title":"Three small RNAs within the 10 kb trypanosome rRNA transcription unit are analogous to domain VII of other eukaryotic 28S rRNAs","volume":"14","author":"TC White","year":"1986","journal-title":"NucleicAcidsRes"},{"issue":"5","key":"ref53","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1093\/nar\/gks1469","article-title":"TDP1 is an HMG chromatin protein facilitating RNA polymerase I transcription in African trypanosomes","volume":"41","author":"MS Narayanan","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"ref54","article-title":"The Meaning of NMD: Translate or Perish","author":"S Brogna","year":"2016","journal-title":"Trends Genet"},{"issue":"18","key":"ref55","doi-asserted-by":"crossref","first-page":"7357","DOI":"10.1093\/nar\/15.18.7357","article-title":"Transcription of the intergenic regions of the tubulin gene cluster of Trypanosoma brucei: evidence for a polycistronic transcription unit in a eukaryote","volume":"15","author":"MA Imboden","year":"1987","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"ref56","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1128\/MCB.13.1.720","article-title":"Temporal order of RNA-processing reactions in trypanosomes: rapid trans splicing precedes polyadenylation of newly synthesized tubulin transcripts","volume":"13","author":"E Ullu","year":"1993","journal-title":"Mol Cell Biol"},{"issue":"12","key":"ref57","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1261\/rna.291506","article-title":"Roles of a Trypanosoma brucei 5'->3' exoribonuclease homolog in mRNA degradation","volume":"12","author":"CH Li","year":"2006","journal-title":"RNA"},{"key":"ref58","first-page":"48","article-title":"New insights into nucleolar structure and function","volume":"7","author":"YW Lam","year":"2015","journal-title":"F1000Prime Rep"},{"issue":"2","key":"ref59","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0166-6851(02)00273-6","article-title":"The second largest subunit of Trypanosoma brucei's multifunctional RNA polymerase I has a unique N-terminal extension domain","volume":"126","author":"B Schimanski","year":"2003","journal-title":"Mol Biochem Parasitol"},{"issue":"1","key":"ref60","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.molbiopara.2006.02.023","article-title":"Purification of an eight subunit RNA polymerase I complex in Trypanosoma brucei","volume":"149","author":"TN Nguyen","year":"2006","journal-title":"Mol Biochem Parasitol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/2045-3701-4-43","article-title":"Perturbations at the ribosomal genes loci are at the centre of cellular dysfunction and human disease","volume":"4","author":"J Diesch","year":"2014","journal-title":"Cell Biosci"},{"issue":"4","key":"ref62","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1128\/MCB.13.4.2441","article-title":"Structural alterations of the nucleolus in mutants of Saccharomyces cerevisiae defective in RNA polymerase I","volume":"13","author":"M Oakes","year":"1993","journal-title":"Mol Cell Biol"},{"issue":"5","key":"ref63","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1093\/nar\/gkt1301","article-title":"Promoter occupancy of the basal class I transcription factor A differs strongly between active and silent VSG expression sites in Trypanosoma brucei","volume":"42","author":"TN Nguyen","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"ref64","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.18632\/oncotarget.2020","article-title":"DNA intercalator BMH-21 inhibits RNA polymerase I independent of DNA damage response","volume":"5","author":"L Colis","year":"2014","journal-title":"Oncotarget"},{"issue":"2","key":"ref65","first-page":"103","article-title":"Design and synthesis of fluoroquinophenoxazines that interact with human telomeric G-quadruplexes and their biological effects","volume":"1","author":"W Duan","year":"2001","journal-title":"Mol Cancer Ther"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0005432","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T00:00:00Z","timestamp":1489622400000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0005432","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T17:17:33Z","timestamp":1589735853000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0005432"}},"subtitle":[],"editor":[{"given":"Jayne","family":"Raper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,3,6]]},"references-count":65,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0005432","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0005432","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,6]]}}}